Logo image of MRAI

MARPAI INC-CLASS A (MRAI) Stock Fundamental Analysis

NASDAQ:MRAI - Nasdaq - US5713542083 - Common Stock - Currency: USD

0.9  -1.04 (-53.61%)

After market: 0.9004 +0 (+0.04%)

Fundamental Rating

2

Overall MRAI gets a fundamental rating of 2 out of 10. We evaluated MRAI against 143 industry peers in the Insurance industry. MRAI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, MRAI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MRAI has reported negative net income.
MRAI had a negative operating cash flow in the past year.
In the past 5 years MRAI always reported negative net income.
MRAI had a negative operating cash flow in each of the past 5 years.
MRAI Yearly Net Income VS EBIT VS OCF VS FCFMRAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -80.54%, MRAI is not doing good in the industry: 97.81% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -80.54%
ROE N/A
ROIC N/A
ROA(3y)-59.97%
ROA(5y)-55.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRAI Yearly ROA, ROE, ROICMRAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 -200 -400

1.3 Margins

MRAI has a better Gross Margin (34.90%) than 91.97% of its industry peers.
The Profit Margin and Operating Margin are not available for MRAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MRAI Yearly Profit, Operating, Gross MarginsMRAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

MRAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MRAI has been increased compared to 1 year ago.
The debt/assets ratio for MRAI is higher compared to a year ago.
MRAI Yearly Shares OutstandingMRAI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M
MRAI Yearly Total Debt VS Total AssetsMRAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

MRAI has an Altman-Z score of -5.04. This is a bad value and indicates that MRAI is not financially healthy and even has some risk of bankruptcy.
MRAI has a better Altman-Z score (-5.04) than 65.69% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.04
ROIC/WACCN/A
WACC6.4%
MRAI Yearly LT Debt VS Equity VS FCFMRAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

MRAI has a Current Ratio of 0.82. This is a bad value and indicates that MRAI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.82, MRAI is in the better half of the industry, outperforming 78.10% of the companies in the same industry.
A Quick Ratio of 0.82 indicates that MRAI may have some problems paying its short term obligations.
MRAI has a Quick ratio of 0.82. This is in the better half of the industry: MRAI outperforms 78.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
MRAI Yearly Current Assets VS Current LiabilitesMRAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

5

3. Growth

3.1 Past

MRAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.44%, which is quite impressive.
Looking at the last year, MRAI shows a very strong growth in Revenue. The Revenue has grown by 25.44%.
EPS 1Y (TTM)45.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.51%
Revenue 1Y (TTM)25.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.65%

3.2 Future

Based on estimates for the next years, MRAI will show a very strong growth in Earnings Per Share. The EPS will grow by 38.31% on average per year.
MRAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 38.93% yearly.
EPS Next Y66.51%
EPS Next 2Y38.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.59%
Revenue Next 2Y38.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

MRAI Yearly Revenue VS EstimatesMRAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
MRAI Yearly EPS VS EstimatesMRAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -1 -2 -3 -4 -5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MRAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MRAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRAI Price Earnings VS Forward Price EarningsMRAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRAI Per share dataMRAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as MRAI's earnings are expected to grow with 38.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.31%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MRAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARPAI INC-CLASS A

NASDAQ:MRAI (5/28/2024, 8:00:01 PM)

After market: 0.9004 +0 (+0.04%)

0.9

-1.04 (-53.61%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-09 2024-05-09/amc
Earnings (Next)08-01 2024-08-01/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners42.01%
Ins Owner Change2.03%
Market Cap9.28M
Analysts82.86
Price Target6.12 (580%)
Short Float %0.38%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.41%
Min Revenue beat(2)-16.78%
Max Revenue beat(2)-2.05%
Revenue beat(4)2
Avg Revenue beat(4)0.29%
Min Revenue beat(4)-16.78%
Max Revenue beat(4)19.46%
Revenue beat(8)5
Avg Revenue beat(8)0.66%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-50%
EPS NQ rev (1m)-13.33%
EPS NQ rev (3m)-155%
EPS NY rev (1m)0.68%
EPS NY rev (3m)-356.25%
Revenue NQ rev (1m)-14.29%
Revenue NQ rev (3m)-67.72%
Revenue NY rev (1m)-12.49%
Revenue NY rev (3m)-61.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.16
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)-1.24
OCFYN/A
SpS3.38
BVpS-1.41
TBVpS-2.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -80.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.9%
FCFM N/A
ROA(3y)-59.97%
ROA(5y)-55.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z -5.04
F-Score3
WACC6.4%
ROIC/WACCN/A
Cap/Depr(3y)38.73%
Cap/Depr(5y)574.66%
Cap/Sales(3y)5.4%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.51%
EPS Next Y66.51%
EPS Next 2Y38.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.65%
Revenue Next Year-2.59%
Revenue Next 2Y38.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.31%
OCF growth 3YN/A
OCF growth 5YN/A